Training in MHealth Prevention with MSM

MSM 的 MHealth 预防培训

基本信息

  • 批准号:
    10673645
  • 负责人:
  • 金额:
    $ 18.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-15 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Abstract Malaysia's HIV epidemic is rapidly expanding with recent evidence suggesting accelerated sexual transmission, especially among men who have sex with men (MSM): 10% in 2008 to 54% in 2016. Biobehavioral surveys suggest high HIV prevalence in MSM being nationally (21.6%) and in Kuala Lumpur (43%). This growing epidemic in MSM is associated with condomless sex (CS), STIs, and high usage of substance (particularly amphetamine-type stimulants; ATS). In Malaysia, both substance use and homosexuality are criminalized, making MSM dually bear the burden of social stigma and discrimination, including in healthcare. Consequently, they are marginalized from traditional, venue-based HIV prevention services, which undermines recommendations by international agencies. To address stigma and discrimination, mHealth (mobile technology to promote health) strategies can deliver prevention messages and guide health decisions anonymously, and thus hold great promise for MSM, especially those using ATS. They can overcome barriers along the HIV prevention cascade that now includes pre-exposure prophylaxis (PrEP). Combined with strong training and mentoring, the proposed projects directly address this need through the conduct of two formative studies. First, information about MSM's preferences of various attributes of PrEP delivery programs, including segmentation of ATS-using MSM, will be assessed. Then, building on the first study, the candidate will develop and test an mHealth-based intervention to overcome barriers along the prevention continuum, including HIV testing, co-occurring sexual and drug risk behaviors and PrEP uptake among Malaysian MSM. Findings from these related projects will provide the candidate with the necessary skills and competencies to develop and test an innovative and tailored primary HIV prevention intervention for MSM. This K01 application for Dr. Shrestha is well-suited to advance the career of the candidate by virtue of his training in intervention design, delivery, and placement, his high productivity in public health research, and his evolving experience with research in the Malaysian context. Over 5 years, he will achieve new skills and experiences to achieve his professional goals and objectives to: 1) gain experience in decision science with advanced quantitative and qualitative skills to become an independent investigator in HIV, substance use, and mHealth intervention for vulnerable populations; 2) develop expertise in mHealth intervention development, testing, implementation, and dissemination that will address specific barriers to HIV prevention services in MSM, especially those with substance use disorders; and 3) develop an independent career path focusing on HIV prevention in MSM using mHealth strategies. To achieve these goals, he has assembled a stellar interdisciplinary team of mentors with expertise in HIV, substance use, intervention design, decision science, advanced biostatistics, and mHealth research. Under their guidance, he will complete relevant didactic work and attend seminars and conduct research to apply the skills needed to become an independent researcher in mHealth-based HIV prevention among MSM.
抽象的 马来西亚的艾滋病毒流行正在迅速扩大,最近的证据表明加速了性行为 传播,尤其是在与男性发生性关系的男性中(MSM):2016年10%,达到54%。 调查表明,在全国范围内(21.6%)和吉隆坡(43%),MSM的HIV患病率很高。这个成长 MSM中的流行与无避孕套性别(CS),性传播感染和物质使用高有关(尤其是 苯丙胺型兴奋剂; ATS)。在马来西亚,物质使用和同性恋都被定为犯罪 使MSM双重地承担社会污名和歧视的负担,包括医疗保健。最后, 它们是从传统的基于场地的艾滋病毒预防服务中被边缘化的,这破坏了 国际机构的建议。为了解决污名和歧视,MHealth(移动技术 促进健康)策略可以传递预防信息并匿名指导健康决策,从而 对MSM,尤其是使用ATS的MSM保持巨大的希望。他们可以克服预防艾滋病毒的障碍 现在包括预防前预防的级联(PREP)。结合强大的培训和指导, 提议的项目通过进行两项形成性研究直接解决了这一需求。首先,信息 关于MSM对准备递送程序的各种属性的偏好,包括对ATS的细分 MSM将进行评估。然后,在第一项研究的基础上,候选人将开发和测试基于MHealth的 干预以克服沿预防连续体的障碍,包括HIV测试,性行为 马来西亚MSM中的毒品风险行为和预付款。这些相关项目的发现将 为候选人提供必要的技能和能力来开发和测试创新和量身定制的 MSM的原发性HIV预防干预。 Shrestha博士的K01申请非常适合推进 候选人在干预设计,交付和安置方面的培训,他的职业生涯高 公共卫生研究中的生产力,以及他在马来西亚背景下研究的经验。超过 5年,他将获得新的技能和经验,以实现其职业目标和目标:1) 具有高级定量和定性技能的决策科学经验,成为独立 艾滋病毒,药物使用和MHealth干预措施的研究人员; 2)发展专业知识 在MHealth干预开发,测试,实施和传播中,将解决特定的 MSM中艾滋病毒预防服务的障碍,尤其是患有药物使用障碍的障碍; 3)发展 使用MHealth策略专注于MSM预防HIV的独立职业道路。为了实现这些目标, 他已经组建了一个杰出的跨学科导师团队,具有艾滋病毒专业知识,药物使用,干预 设计,决策科学,高级生物统计学和MHealth研究。在他们的指导下,他将完成 相关的教学工作并参加研讨会并进行研究,以运用成为一个技能 MSM中基于MHealth的HIV预防的独立研究人员。

项目成果

期刊论文数量(54)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Suicidal ideation, plan, and attempt among men who have sex with men in Nepal: Findings from a cross-sectional study.
  • DOI:
    10.1371/journal.pgph.0002348
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Using individual stated-preferences to optimize HIV self-testing service delivery among men who have sex with men (MSM) in Malaysia: results from a conjoint-based analysis.
  • DOI:
    10.1186/s12889-020-09832-w
  • 发表时间:
    2020-11-25
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Shrestha R;Alias H;Wong LP;Altice FL;Lim SH
  • 通讯作者:
    Lim SH
Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
  • DOI:
    10.1016/j.drugpo.2021.103558
  • 发表时间:
    2022-03
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Bachireddy, Chethan;Shrestha, Roman;Bromberg, Daniel J.;Azbel, Lyu;Kurmanalieva, Ainura;Wegman, Martin;Shumskaya, Natalya;Rozanova, Julia;Meyer, Jaimie P.;Altice, Frederick L.
  • 通讯作者:
    Altice, Frederick L.
Feasibility and Acceptability of an mHealth-Based Approach as an HIV Prevention Strategy Among People Who Use Drugs on Pre-Exposure Prophylaxis.
基于移动医疗的方法作为艾滋病毒预防策略在使用药物进行暴露前预防的人群中的可行性和可接受性。
  • DOI:
    10.2147/ppa.s236794
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Shrestha,Roman;Altice,FrederickL;DiDomizio,Elizabeth;Sibilio,Brian;Ranjit,YerinaS;Copenhaver,MichaelM
  • 通讯作者:
    Copenhaver,MichaelM
Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder.
  • DOI:
    10.1016/j.jsat.2021.108387
  • 发表时间:
    2021-10
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Mistler CB;Sullivan MC;Copenhaver MM;Meyer JP;Roth AM;Shenoi SV;Edelman EJ;Wickersham JA;Shrestha R
  • 通讯作者:
    Shrestha R
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Roman Shrestha其他文献

Roman Shrestha的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Roman Shrestha', 18)}}的其他基金

Integrated online-to-offline (O2O) model of care for HIV prevention and treatment among men who have sex with men
男男性行为者艾滋病预防和治疗的线上线下(O2O)一体化护理模式
  • 批准号:
    10548402
  • 财政年份:
    2022
  • 资助金额:
    $ 18.14万
  • 项目类别:
Integrated online-to-offline (O2O) model of care for HIV prevention and treatment among men who have sex with men
男男性行为者艾滋病预防和治疗的线上线下(O2O)一体化护理模式
  • 批准号:
    10665762
  • 财政年份:
    2022
  • 资助金额:
    $ 18.14万
  • 项目类别:
An online HIV self-testing intervention with online-to-offline linkage to care for transgender women
在线艾滋病自检干预,线上线下联动,关爱跨性别女性
  • 批准号:
    10772677
  • 财政年份:
    2022
  • 资助金额:
    $ 18.14万
  • 项目类别:
Improving HIV testing and PrEP for transgender women through mHealth
通过移动医疗改善跨性别女性的艾滋病毒检测和 PrEP
  • 批准号:
    10258220
  • 财政年份:
    2021
  • 资助金额:
    $ 18.14万
  • 项目类别:
Development and Testing of a Mobile Application to Enhance HIV Prevention Cascade in Malaysian MSM
开发和测试移动应用程序以加强马来西亚男男性接触者的艾滋病毒预防级联
  • 批准号:
    10367278
  • 财政年份:
    2021
  • 资助金额:
    $ 18.14万
  • 项目类别:
Improving HIV testing and PrEP for transgender women through mHealth
通过移动医疗改善跨性别女性的艾滋病毒检测和 PrEP
  • 批准号:
    10398983
  • 财政年份:
    2021
  • 资助金额:
    $ 18.14万
  • 项目类别:
Development and Testing of a Mobile Application to Enhance HIV Prevention Cascade in Malaysian MSM
开发和测试移动应用程序以加强马来西亚男男性接触者的艾滋病毒预防级联
  • 批准号:
    10261542
  • 财政年份:
    2021
  • 资助金额:
    $ 18.14万
  • 项目类别:
Development and Testing of a Mobile Application to Enhance HIV Prevention Cascade in Malaysian MSM
开发和测试移动应用程序以加强马来西亚男男性接触者的艾滋病毒预防级联
  • 批准号:
    10673162
  • 财政年份:
    2020
  • 资助金额:
    $ 18.14万
  • 项目类别:
Integrated rapid access to HIV prevention program for people who inject drugs (iRaPID)
注射吸毒者综合快速获得艾滋病毒预防计划 (iRaPID)
  • 批准号:
    10082915
  • 财政年份:
    2020
  • 资助金额:
    $ 18.14万
  • 项目类别:
Integrated Rapid Access to HIV Prevention Program for People Who Inject Drugs (RAPID)
注射吸毒者综合快速艾滋病毒预防计划 (RAPID)
  • 批准号:
    10224917
  • 财政年份:
    2020
  • 资助金额:
    $ 18.14万
  • 项目类别:

相似国自然基金

基于腔光机械效应的石墨烯光纤加速度计研究
  • 批准号:
    62305039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于自持相干放大的高精度微腔光力加速度计研究
  • 批准号:
    52305621
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
位移、加速度双控式自复位支撑-高层钢框架结构的抗震设计方法及韧性评估研究
  • 批准号:
    52308484
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
高离心加速度行星排滚针轴承多场耦合特性与保持架断裂失效机理研究
  • 批准号:
    52305047
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
基于偏心光纤包层光栅的矢量振动加速度传感技术研究
  • 批准号:
    62305269
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

RP5 MPT Study
RP5 MPT 研究
  • 批准号:
    10595905
  • 财政年份:
    2023
  • 资助金额:
    $ 18.14万
  • 项目类别:
IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023
IAS 2023,第 12 届 IAS HIV 科学会议,澳大利亚布里斯班,虚拟会议,2023 年 7 月 23-26 日
  • 批准号:
    10696505
  • 财政年份:
    2023
  • 资助金额:
    $ 18.14万
  • 项目类别:
Developing a Risk Index for Functional Decline in Middle-Aged and Older Adults with HIV
制定中老年艾滋病毒感染者功能衰退的风险指数
  • 批准号:
    10762280
  • 财政年份:
    2023
  • 资助金额:
    $ 18.14万
  • 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM) Research Core & MHD-CE
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
  • 批准号:
    10686545
  • 财政年份:
    2023
  • 资助金额:
    $ 18.14万
  • 项目类别:
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
CAPRISA CASCADE 临床试验网络临床研究网站
  • 批准号:
    10754981
  • 财政年份:
    2023
  • 资助金额:
    $ 18.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了